Getting a foothold in the biotech industry isn’t easy. If you have a game-changing biotech idea that will make a difference for cancer patients, you’ll need funding and entrepreneurship expertise to take it from lab to market. Knowing where to start to attract the capital needed to move your project forward isn’t always obvious. This session illuminates the various non-dilutive and dilutive funding pathways that innovators can take to advance their technologies and win investments. Attendees will receive a detailed overview of such pathways at the NCI SBIR Development Center from NCI SBIR Director, who will then lead a roundtable discussion with industry leaders as they provide perspective on how to obtain third-party financing and strategic partnerships. Audience members will leave this session feeling more confident and knowledgeable of the approaches they can take to secure critical funding for their commercialization journeys.